Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-13-013412)

Filing Details

Accession Number:: 0001127602-13-013412
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-04 17:48:45
Reporting Period:: 2013-04-02

Filing Date:: 2013-04-04
Accepted Time:: 2013-04-04 17:48:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
820096	Perrigo Co	PRGO	Pharmaceutical Preparations (2834)	382799573

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1398276	Thomas Farrington	C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010	Senior Vp And Cio	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-04-02	927	$58.82	1,967	No	4	M	Direct
Common Stock	Disposition	2013-04-02	927	$120.00	1,040	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option Right to Buy	Disposition	2013-04-02	927	$0.00	927	$58.82

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
926	2011-08-19	2020-08-19	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,098	Indirect	By 401(k) Plan

Footnotes

This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on December 6, 2012. This 10b5-1 sales plan will expire on the close of business September 30, 2013.